These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 25027740

  • 21. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.
    Pardo A, Stöcker M, Kampmeier F, Melmer G, Fischer R, Thepen T, Barth S.
    Cancer Immunol Immunother; 2012 Oct; 61(10):1617-26. PubMed ID: 22350071
    [Abstract] [Full Text] [Related]

  • 22. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
    Hjortland GO, Garman-Vik SS, Juell S, Olsen OE, Hirschberg H, Fodstad O, Engebraaten O.
    J Neurosurg; 2004 Feb; 100(2):320-7. PubMed ID: 15086240
    [Abstract] [Full Text] [Related]

  • 23. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
    Fischer A, Wolf I, Fuchs H, Masilamani AP, Wolf P.
    Toxins (Basel); 2020 Nov 28; 12(12):. PubMed ID: 33260619
    [Abstract] [Full Text] [Related]

  • 24. Pseudomonas Exotoxin A-Based Immunotherapy Targeting CCK2R-Expressing Colorectal Malignancies: An In Vitro and In Vivo Evaluation.
    Chang J, Liu X, Ren H, Lu S, Li M, Zhang S, Zhao K, Li H, Zhou X, Peng L, Liu Z, Hu P.
    Mol Pharm; 2021 Jun 07; 18(6):2285-2297. PubMed ID: 33998814
    [Abstract] [Full Text] [Related]

  • 25. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D, Kuan CT, Payne J, Kihara A, Murray A, Wang LM, Alimandi M, Pierce JH, Pastan I, Lippman ME.
    Clin Cancer Res; 1998 Apr 07; 4(4):993-1004. PubMed ID: 9563895
    [Abstract] [Full Text] [Related]

  • 26. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
    Brinkmann U, Lee BK, Pastan I.
    J Immunol; 1993 Apr 01; 150(7):2774-82. PubMed ID: 8454854
    [Abstract] [Full Text] [Related]

  • 27. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK, Kasprzyk PG, Bird RE, Pastan I, King CR.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5867-71. PubMed ID: 1352878
    [Abstract] [Full Text] [Related]

  • 28. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.
    Brinkmann U, Pai LH, FitzGerald DJ, Willingham M, Pastan I.
    Proc Natl Acad Sci U S A; 1991 Oct 01; 88(19):8616-20. PubMed ID: 1924323
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T, Tanaka M, Hasui K, Shirahama H, Kitajima S, Yonezawa S, Xu B, Matsuyama T.
    Clin Exp Immunol; 2010 Aug 01; 161(2):348-56. PubMed ID: 20550546
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ, Pastan I.
    Biochem Soc Trans; 1992 Nov 01; 20(4):731-4. PubMed ID: 1487051
    [No Abstract] [Full Text] [Related]

  • 35. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells.
    Du X, Ho M, Pastan I.
    J Immunother; 2007 Sep 01; 30(6):607-13. PubMed ID: 17667524
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo antitumor effects of the recombinant immunotoxin IL6(T23)-PE38KDEL in multiple myeloma.
    Guo DJ, Han JS, Li YS, Liu ZS, Lu SY, Ren HL.
    Oncol Lett; 2012 Aug 01; 4(2):311-318. PubMed ID: 22844376
    [Abstract] [Full Text] [Related]

  • 38. Cintredekin besudotox in treatment of malignant glioma.
    Mut M, Sherman JH, Shaffrey ME, Schiff D.
    Expert Opin Biol Ther; 2008 Jun 01; 8(6):805-12. PubMed ID: 18476792
    [Abstract] [Full Text] [Related]

  • 39. Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.
    Behdani M, Zeinali S, Karimipour M, Khanahmad H, Schoonooghe S, Aslemarz A, Seyed N, Moazami-Godarzi R, Baniahmad F, Habibi-Anbouhi M, Hassanzadeh-Ghassabeh G, Muyldermans S.
    N Biotechnol; 2013 Jan 25; 30(2):205-9. PubMed ID: 23031816
    [Abstract] [Full Text] [Related]

  • 40. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.
    Simon N, Antignani A, Sarnovsky R, Hewitt SM, FitzGerald D.
    J Natl Cancer Inst; 2016 Aug 25; 108(8):. PubMed ID: 27075852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.